Literature DB >> 19497740

Tra1 as a screening target for transcriptional activation domain discovery.

Chinmay Y Majmudar1, Anne E Labut, Anna K Mapp.   

Abstract

There is tremendous interest in developing activator artificial transcription factors that functionally mimic endogenous transcriptional activators for use as mechanistic probes, as components of synthetic cell circuitry, and in transcription-targeted therapies. Here, we demonstrate that a phage display selection against the transcriptional activation domain binding motif of the coactivator Tra1(TRRAP) produces distinct sequences that function with similar binding modes and potency as natural activators. These findings set the stage for binding screens with small molecule libraries against TAD binding motifs to yield next-generation small molecule TADs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497740      PMCID: PMC4322765          DOI: 10.1016/j.bmcl.2009.05.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  38 in total

1.  Positive and negative regulation of endogenous genes by designed transcription factors.

Authors:  R R Beerli; B Dreier; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  In vivo requirement of activator-specific binding targets of mediator.

Authors:  J M Park; H S Kim; S J Han; M S Hwang; Y C Lee; Y J Kim
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  SAGA is an essential in vivo target of the yeast acidic activator Gal4p.

Authors:  S R Bhaumik; M R Green
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

4.  Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.

Authors:  Penny G Ard; Chandrima Chatterjee; Sudeesha Kunjibettu; Leon R Adside; Lisa E Gralinski; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

5.  Function of a eukaryotic transcription activator during the transcription cycle.

Authors:  James Fishburn; Neeman Mohibullah; Steven Hahn
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

6.  Targets of the Gal4 transcription activator in functional transcription complexes.

Authors:  Wendy M Reeves; Steven Hahn
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Enhanced protein production by engineered zinc finger proteins.

Authors:  Andreas Reik; Yuanyue Zhou; Trevor N Collingwood; Lyndon Warfe; Victor Bartsevich; Yanhong Kong; Karla A Henning; Barrett K Fallentine; Lei Zhang; Xiaohong Zhong; Yann Jouvenot; Andrew C Jamieson; Edward J Rebar; Casey C Case; Alan Korman; Xiao-Yong Li; Amelia Black; David J King; Philip D Gregory
Journal:  Biotechnol Bioeng       Date:  2007-08-01       Impact factor: 4.530

8.  An activator target in the RNA polymerase II holoenzyme.

Authors:  S S Koh; A Z Ansari; M Ptashne; R A Young
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

9.  Genetic reprogramming of tumor cells by zinc finger transcription factors.

Authors:  Pilar Blancafort; Emily I Chen; Beatriz Gonzalez; Sharon Bergquist; Andries Zijlstra; Daniel Guthy; Arndt Brachat; Ruud H Brakenhoff; James P Quigley; Dirk Erdmann; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

10.  Modulation of drug resistance by artificial transcription factors.

Authors:  Pilar Blancafort; Mario P Tschan; Sharon Bergquist; Daniel Guthy; Arndt Brachat; Dennis A Sheeter; Bruce E Torbett; Dirk Erdmann; Carlos F Barbas
Journal:  Mol Cancer Ther       Date:  2008-03-04       Impact factor: 6.261

View more
  3 in total

1.  Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.

Authors:  Chinmay Y Majmudar; Jonas W Højfeldt; Carl J Arevang; William C Pomerantz; Jessica K Gagnon; Pamela J Schultz; Laura C Cesa; Conor H Doss; Steven P Rowe; Victor Vásquez; Giselle Tamayo-Castillo; Tomasz Cierpicki; Charles L Brooks; David H Sherman; Anna K Mapp
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-08       Impact factor: 15.336

2.  The 9aaTAD Is Exclusive Activation Domain in Gal4.

Authors:  Martin Piskacek; Marek Havelka; Martina Rezacova; Andrea Knight
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

Review 3.  Nucleosome distortion as a possible mechanism of transcription activation domain function.

Authors:  Tamara Y Erkina; Alexandre M Erkine
Journal:  Epigenetics Chromatin       Date:  2016-09-20       Impact factor: 4.954

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.